AU4332399A - Rna polymerase chain reaction - Google Patents

Rna polymerase chain reaction

Info

Publication number
AU4332399A
AU4332399A AU43323/99A AU4332399A AU4332399A AU 4332399 A AU4332399 A AU 4332399A AU 43323/99 A AU43323/99 A AU 43323/99A AU 4332399 A AU4332399 A AU 4332399A AU 4332399 A AU4332399 A AU 4332399A
Authority
AU
Australia
Prior art keywords
chain reaction
polymerase chain
rna polymerase
rna
reaction
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU43323/99A
Other languages
English (en)
Inventor
Cheng-Ming Chuong
Shi-Lung Lin
Randall Bruce Widelitz
Shao-Yao Ying
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
CHENG MING CHUONG
SHI LUNG LIN
Original Assignee
CHENG MING CHUONG
SHI LUNG LIN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by CHENG MING CHUONG, SHI LUNG LIN filed Critical CHENG MING CHUONG
Publication of AU4332399A publication Critical patent/AU4332399A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • C12P19/28—N-glycosides
    • C12P19/30—Nucleotides
    • C12P19/34—Polynucleotides, e.g. nucleic acids, oligoribonucleotides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C12N15/1096—Processes for the isolation, preparation or purification of DNA or RNA cDNA Synthesis; Subtracted cDNA library construction, e.g. RT, RT-PCR
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6865—Promoter-based amplification, e.g. nucleic acid sequence amplification [NASBA], self-sustained sequence replication [3SR] or transcription-based amplification system [TAS]

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Analytical Chemistry (AREA)
  • Immunology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Plant Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
AU43323/99A 1999-06-04 1999-06-04 Rna polymerase chain reaction Abandoned AU4332399A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/US1999/012461 WO2000075356A1 (fr) 1999-06-04 1999-06-04 Amplification en chaine d'arn par polymerase

Publications (1)

Publication Number Publication Date
AU4332399A true AU4332399A (en) 2000-12-28

Family

ID=22272895

Family Applications (1)

Application Number Title Priority Date Filing Date
AU43323/99A Abandoned AU4332399A (en) 1999-06-04 1999-06-04 Rna polymerase chain reaction

Country Status (2)

Country Link
AU (1) AU4332399A (fr)
WO (1) WO2000075356A1 (fr)

Families Citing this family (36)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002064835A2 (fr) * 2001-01-31 2002-08-22 Ambion, Inc. Methodes d'analyse d'empreintes d'acides nucleiques
JP2002262882A (ja) * 2001-03-12 2002-09-17 Nisshinbo Ind Inc Ｒｎａの増幅法
ATE551431T1 (de) * 2001-05-14 2012-04-15 Henry Hongjun Ji Neues verfahren zur klonierung von sequenzen variabler domänen des immunologischen genrepertoires
US7838270B2 (en) 2001-05-22 2010-11-23 The University Of Chicago Target-dependent transcription using deletion mutants of N4 RNA polymerase
US8137911B2 (en) 2001-05-22 2012-03-20 Cellscript, Inc. Preparation and use of single-stranded transcription substrates for synthesis of transcription products corresponding to target sequences
US20040161741A1 (en) 2001-06-30 2004-08-19 Elazar Rabani Novel compositions and processes for analyte detection, quantification and amplification
US9261460B2 (en) 2002-03-12 2016-02-16 Enzo Life Sciences, Inc. Real-time nucleic acid detection processes and compositions
US9777312B2 (en) 2001-06-30 2017-10-03 Enzo Life Sciences, Inc. Dual polarity analysis of nucleic acids
EP1275738A1 (fr) * 2001-07-11 2003-01-15 Roche Diagnostics GmbH Procédé pour la synthèse aléatoire et l'amplification d'ADNc
DE10143106C1 (de) * 2001-09-03 2002-10-10 Artus Ges Fuer Molekularbiolog Vermehrung von Ribonukleinsäuren
US7354742B2 (en) * 2002-02-22 2008-04-08 Ortho-Mcneil Pharmaceutical, Inc. Method for generating amplified RNA
EP1371726A1 (fr) * 2002-06-14 2003-12-17 Rijksuniversiteit Groningen Procédé d'amplification d'ARN
US20040197802A1 (en) 2002-11-21 2004-10-07 Dahl Gary A. Methods for using primers that encode one strand of a double-stranded promoter
EP2471924A1 (fr) 2004-05-28 2012-07-04 Asuragen, INC. Procédés et compositions impliquant du microARN
EP2302055B1 (fr) 2004-11-12 2014-08-27 Asuragen, Inc. Procédés et compositions impliquant l'ARNmi et des molécules inhibitrices de l'ARNmi
CA2649325C (fr) 2006-04-14 2019-01-08 Epicentre Technologies Corporation Kits et procedes pour la generation d'arn coiffe en 5'
WO2008141514A1 (fr) * 2007-05-17 2008-11-27 Wondergen Bio-Medicine Technology Co., Ltd. Pcr de substitution de système
WO2009006438A2 (fr) 2007-06-29 2009-01-08 Epicentre Technologies Corporation Adn de copie et arn sens
EP2198050A1 (fr) 2007-09-14 2010-06-23 Asuragen, INC. Microarn exprimés de manière différentielle dans le cancer du col de l'utérus et leurs utilisations
US8258111B2 (en) 2008-05-08 2012-09-04 The Johns Hopkins University Compositions and methods related to miRNA modulation of neovascularization or angiogenesis
EP2600901B1 (fr) 2010-08-06 2019-03-27 ModernaTX, Inc. Compositions pharmaceutiques a base d'acides nucléiques modifiés et leur utilisation medicale
ES2737960T3 (es) 2010-10-01 2020-01-17 Modernatx Inc Nucleósidos, nucleótidos y ácidos nucleicos modificados y sus usos
AU2012236099A1 (en) 2011-03-31 2013-10-03 Moderna Therapeutics, Inc. Delivery and formulation of engineered nucleic acids
US9464124B2 (en) 2011-09-12 2016-10-11 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
WO2013040251A2 (fr) 2011-09-13 2013-03-21 Asurgen, Inc. Méthodes et compositions incluant mir-135b, permettant de faire la distinction entre un cancer du pancréas et une maladie pancréatique bénigne
EP3682905B1 (fr) 2011-10-03 2021-12-01 ModernaTX, Inc. Nucléosides, nucléotides et acides nucléiques modifiés et leurs utilisations
EP2791160B1 (fr) 2011-12-16 2022-03-02 ModernaTX, Inc. Compositions de mrna modifiés
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
US9303079B2 (en) 2012-04-02 2016-04-05 Moderna Therapeutics, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
AU2013243948A1 (en) 2012-04-02 2014-10-30 Moderna Therapeutics, Inc. Modified polynucleotides for the production of proteins associated with human disease
EP4074834A1 (fr) 2012-11-26 2022-10-19 ModernaTX, Inc. Arn à terminaison modifiée
US8980864B2 (en) 2013-03-15 2015-03-17 Moderna Therapeutics, Inc. Compositions and methods of altering cholesterol levels
WO2015048744A2 (fr) 2013-09-30 2015-04-02 Moderna Therapeutics, Inc. Polynucléotides codant des polypeptides de modulation immunitaire
CA2926218A1 (fr) 2013-10-03 2015-04-09 Moderna Therapeutics, Inc. Polynucleotides codant pour un recepteur de lipoproteines de faible densite
KR20220041211A (ko) 2019-08-09 2022-03-31 넛크래커 테라퓨틱스 인코포레이티드 치료학적 조성물로부터 물질을 제거하기 위한 제조 방법 및 장치

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1993018176A1 (fr) * 1992-03-11 1993-09-16 Dana-Farber Cancer Institute Procedes de clonage d'arn messager
DE69332852T2 (de) * 1992-09-11 2003-12-04 Hoffmann La Roche Nachweis von Nukleinsäuren im Blut

Also Published As

Publication number Publication date
WO2000075356A1 (fr) 2000-12-14

Similar Documents

Publication Publication Date Title
AU4332399A (en) Rna polymerase chain reaction
AU2001268513A1 (en) Nucleic acid accessible hybridization sites
AU4518601A (en) Microarray hybridization chamber
AU3243099A (en) Multi-zone polymerase/ligase chain reaction
AU3369900A (en) Gene silencing
AU3678100A (en) Biosensor
AU3719700A (en) Enzymatic dna molecules that contain modified nucleotides
AU2001279134A1 (en) Nucleotide incorporating enzymes
AU2003272203A1 (en) Multiplex nucleic acid reactions
AU2001272482A1 (en) Osteolevin gene polymorphisms
AUPS076902A0 (en) Novel selective polymerase chain reaction
AU2001285844A1 (en) Nucleotide sequences which code for the meth gene
AU2002327236A1 (en) Multiplex nucleic acid reactions
AU2003269908A1 (en) Multiplex nucleic acid reactions
DE69833112D1 (en) Rna polymerase
AU2002245107A1 (en) Improved biochip
AU2877000A (en) Photo-induced nucleic acid hybridization
AU1812801A (en) Short shared nucleotide sequences
AU7461900A (en) Nucleotide sequences
AU6488800A (en) Dna sequences specific to rice centromeres
AU6871900A (en) Tsg-like gene
AU1870000A (en) Gene therapy-2
GB9905644D0 (en) Dna
AU1051701A (en) Catalytic nucleic acid sequences
AU2001294299A1 (en) Immobilized dna polymerase

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase